Search Count: 36
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE Ligands: ZN, FQH, GOL, CL, DMS |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE Ligands: ZN, FQ5, DMS, CL, GOL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.31 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE Ligands: ZN, FO2, GOL, DMS, CL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE Ligands: ZN, FQB, DMS, GOL, CL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE Ligands: ZN, FQE, DMS, CL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.38 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE Ligands: ZN, FOW, CL, GOL, DMS |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE Ligands: ZN, FO2, DMS, GOL, CL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE Ligands: ZN, FQN, CL, DMS |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.81 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE Ligands: ZN, FQQ, DMS, CL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.34 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE Ligands: ZN, FNQ, DMS, GOL, CL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.38 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE Ligands: ZN, FO8, CL, DMS, GOL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE Ligands: ZN, MN, FQ5, DMS, EDO |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE Ligands: ZN, MN, EDO, PO4, FO2, DMS |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE Ligands: ZN, MN, DMS, EDO, PO4, FQK |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2019-06-12 Classification: OXIDOREDUCTASE Ligands: ZN, MN, DMS, PO4, FQN, EDO |
 |
Design And Synthesis Of A Pan-Jak Kinase Inhibitor Clinical Candidate (Pf-06263276) Suitable For The Treatment Of Inflammatory Diseases Of The Lungs And Skin
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.69 Å Release Date: 2017-01-11 Classification: Transferase/Transferase Inhibitor Ligands: 7GZ |
 |
Design And Synthesis Of A Pan-Jak Kinase Inhibitor Clinical Candidate (Pf-06263276) Suitable For Inhaled And Topical Delivery For The Treatment Of Inflammatory Diseases Of The Lungs And Skin
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2017-01-11 Classification: Transferase/Transferase Inhibitor Ligands: 7GY |
 |
Design And Synthesis Of A Pan-Jak Kinase Inhibitor Clinical Candidate (Pf-06263276) Suitable For Inhaled And Topical Delivery For The Treatment Of Inflammatory Diseases Of The Lungs And Skin
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2017-01-11 Classification: Transferase/Transferase Inhibitor Ligands: 7GX |
 |
Design And Synthesis Of A Pan-Jak Kinase Inhibitor Clinical Candidate (Pf-06263276) Suitable For Inhaled And Topical Delivery For The Treatment Of Inflammatory Diseases Of The Lungs And Skin
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.06 Å Release Date: 2017-01-11 Classification: Transferase/Transferase Inhibitor Ligands: 7GV |
 |
Design And Synthesis Of A Pan-Jak Kinase Inhibitor Clinical Candidate (Pf-06263276) Suitable For Inhaled And Topical Delivery For The Treatment Of Inflammatory Diseases Of The Lungs And Skin
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2017-01-11 Classification: Transferase/Transferase Inhibitor Ligands: 7GT |